MIDAS is involved in innovative methodological developments.

Current projects:

QALY Alternatives: Exploring a framework for measuring cost-effectiveness where quality-adjusted life years (QALYs) may not reflect outcomes, including innovative technologies e.g. mHealth, End-of-Life. (QALY is a generic measure of disease burden, including both the quality and the quantity of life lived. It is used in economic evaluations to assess the value of medical interventions).

Discrete Choice Experiments: Building expertise in discrete choice experiments (DCE). (DCEs are a popular stated preference tool in health economics. They have been used to address policy questions, establish consumer preferences for health and healthcare, and value health states, among other applications).